Agency Information Collection Activities: Proposed Collection; Comment Request, 44033-44035 [2014-17660]
Download as PDF
<![CDATA[
Federal Register / Vol. 79, No. 145 / Tuesday, July 29, 2014 / Notices
from communicating with their
competitors about rates or prices, with
a proviso permitting public posting of
rates and a second proviso that permits
Respondents to buy or sell barcodes.
Section II, Paragraph B prohibits
Respondents from entering into,
participating in, maintaining,
organizing, implementing, enforcing,
inviting, offering, or soliciting an
agreement with any competitor to
divide markets, to allocate customers, or
to fix prices.
Section II, Paragraph C bars
Respondents from urging any
competitor to raise, fix or maintain its
price or rate levels or to limit or reduce
service terms or levels.
Sections III–VI of the Proposed Orders
impose certain standard reporting and
compliance requirements on
Respondents.
The Proposed Orders will expire in 20
years.
By direction of the Commission.
Donald S. Clark,
Secretary.
[FR Doc. 2014–17785 Filed 7–28–14; 8:45 am]
BILLING CODE 6750–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency for Healthcare Research and
Quality
Agency Information Collection
Activities: Proposed Collection;
Comment Request
Agency for Healthcare Research
and Quality, HHS.
ACTION: Notice.
AGENCY:
This notice announces the
intention of the Agency for Healthcare
Research and Quality (AHRQ) to request
that the Office of Management and
Budget (OMB) approve the proposed
information collection project: ‘‘Phase II
of a Longitudinal Program Evaluation of
Health and Human Services (HHS)
Healthcare Associated Infections (HAI)
National Action Plan (NAP).’’ In
accordance with the Paperwork
Reduction Act, 44 U.S.C. 3501–3521,
AHRQ invites the public to comment on
this proposed information collection.
This proposed information collection
was previously published in the Federal
Register on April 23rd and allowed 60
days for public comment. No comments
were received. The purpose of this
notice is to allow an additional 30 days
for public comment.
DATES: Comments on this notice must be
received by August 28, 2014.
rmajette on DSK2TPTVN1PROD with NOTICES
SUMMARY:
VerDate Mar<15>2010
15:02 Jul 28, 2014
Jkt 232001
Written comments should
be submitted to: Doris Lefkowitz,
Reports Clearance Officer, AHRQ, by
email at doris.lefkowitz@AHRQ.hhs.gov.
Copies of the proposed collection
plans, data collection instruments, and
specific details on the estimated burden
can be obtained from the AHRQ Reports
Clearance Officer.
FOR FURTHER INFORMATION CONTACT:
Doris Lefkowitz, AHRQ Reports
Clearance Officer, (301) 427–1477, or by
email at doris.lefkowitz@AHRQ.hhs.gov.
SUPPLEMENTARY INFORMATION:
ADDRESSES:
Proposed Project
Phase II of a Longitudinal Program
Evaluation of Health and Human
Services (HHS) Healthcare Associated
Infections (HAI) National Action Plan
(NAP)
This evaluation of HHS’ Healthcare
Associated Infections National Action
Plan will assess the efficacy, efficiency
and coordination of federal efforts to
mitigate and prevent Healthcare
Associated Infections (HAIs). As such,
the evaluation represents a critical
component of AHRQ’s mission to
promote health care quality
improvement.
HAIs are infections that patients
acquire while receiving treatment for
other conditions while in a health care
setting. They affect care in hospitals,
-hereafter referred to as ‘‘acute care-,’’
ambulatory care settings, and long-term
care facilities, and represent a
significant cause of illness and death in
the United States. Over one million
HAIs occur across health care settings
every year.
In 2008, amidst growing demands on
the health care system, rising health
care costs, and increasing concerns
about antimicrobial-resistant pathogens,
HHS established a senior-level Steering
Committee for the Prevention of HAIs.
Charged with improving coordination
and maximizing the efficiency of
prevention efforts across HHS, the
Steering Committee released the first
‘‘National Action Plan to Prevent Health
Care-Associated Infections’’ (HAI NAP)
in 2009. This plan outlined a systematic
and phased approach to reducing HAIs
and associated morbidity, mortality, and
costs. Phase One of HAI NAP, which
concluded in 2012, focused on HAI
prevention in acute care hospitals,
where data on prevention and the
capacity to measure improvement were
most complete. Additionally, the plan
set specific targets for reducing rates of
six high priority HAIs or specific
causative organisms: Surgical site
infection (SSI), central-line associated
bloodstream infection (CLABSI),
PO 00000
Frm 00034
Fmt 4703
Sfmt 4703
44033
ventilator-associated pneumonia (VAP),
catheter-associated urinary tract
infection (CAUTI), Clostridium difficile
infection, and methicillin-resistant
Staphylococcus aureus infection
(MRSA).
Phase II of the Action Plan, entitled
National Action Plan to Prevent
Healthcare-Associated Infections:
Roadmap to Elimination was released in
April 2012. Phase 11 expanded the
Action Plan to include prevention of
HAIs in ambulatory surgical centers
(ASCs) and end-stage renal disease
(ESRD) facilities, and increasing
influenza vaccination coverage of health
care personnel. Phase III of the HAI
NAP, released for public comment in
April 2013, further expanded the Action
Plan to include prevention of HAIs in
long-term care facilities.
Evaluation of HAI NAP. In 2009,
AHRQ funded an independent, outside
evaluation of HHS’ HAI prevention
efforts, as guided by the Action Plan.
The goals of this evaluation were to: (1)
Record the content and scope of the
Action Plan, its current design, its
progress, and impact on the future; (2)
establish baseline data and provide
additional information on the HAT
landscape prior to and following the
initiation of the Action Plan effort; and
(3) provide strategic insights from
ongoing processes for reducing HAIs
and outcomes of these processes.
The current evaluation will expand
upon this initial effort, encompassing
the additional health care settings
outlined in Phases H and III of the HAI
NAP.
The goals of this Phase II evaluation
are to:
1. Identify commonalities, gaps,
themes, and opportunities for
collaboration across six Federal quality
improvement and patient safety efforts
to eliminate HAIs; and
2. highlight actionable opportunities
across HHS to collaborate and
efficiently utilize resources in these
quality improvement and patient safety
efforts; and
3. assess the unique and aggregate
contributions of each quality
improvement and patient safety effort to
the mitigation and prevention of HAIs.
This study is being conducted by
AHRQ through its contractor, Insight
Policy Research, Inc. and its
subcontractors, IMPAQ International
and RAND Corporation, pursuant to
AHRQ’s statutory authority to conduct
and support research and evaluations on
health care and on systems for the
delivery of such care, including
activities with respect to the quality,
effectiveness, efficiency,
appropriateness and value of health care
E:\FR\FM\29JYN1.SGM
29JYN1
44034
Federal Register / Vol. 79, No. 145 / Tuesday, July 29, 2014 / Notices
services and with respect to quality
measurement and improvement. 42
U.S.C. 299a(a)(1) and (2).
Method of Collection
To achieve the goals of the HAI NAP
evaluation, the following data
collections will be implemented:
Semi-structured interviews. Key
informant interviews with stakeholders
of the HAI National Action Plan or the
Quality Improvement (QI) initiatives
that the Action Plan seeks to coordinate
and align. These stakeholders will have
knowledge of the QI initiatives as
implemented in acute care, ambulatory
care, long-term care or ESRD facilities.
AHRQ plans to conduct 33 interviews
each year, over the course of two years.
The semi-structured interviews will
inform the process evaluation.
AHRQ will use the interview data to
assess the processes and methods used,
results achieved, and lessons learned
from patient quality and safety programs
that are directed at reducing the
incidence of HAIs. This information
will enable AHRQ to identify
redundancies in program efforts and
provide effective approaches for
coordinating and aligning Federal
efforts to prevent the incidence of HAIs.
Finally, collecting data from these
stakeholders will allow AHRQ to detect
gaps in the HAI science base and
opportunities for funding additional
projects focused on generating and
implementing knowledge on preventing
HAIs.
The information gathered through the
key informant interviews will be
presented to members of a Federal
Action Working Group (FAWG),
comprising representatives from the
various Federal agencies and operating
divisions of MIS who are actively
involved in the HAI NAP. Presentations
to the FAWG will provide continual and
rapid-cycle feedback on evaluation
findings. This feedback will accomplish
several goals—namely, it will apprise
the FAWG members of the study’s
formative findings, provide a medium to
obtain feedback from the FAWG
regarding the unique and aggregate
impact of the national programs, and
engage the FAWG in a discussion about
gaps and future requirements.
Ultimately, the information gathered
through this data collection effort will
appear in annual reports, along with
results of secondary data analyses.
These reports will provide AHRQ and
HHS with comprehensive, evaluative
findings across and within individual
patient safety programs as well as
findings specific to the HAI NAP, and
the extent to which the goals outlined
in the plan have been achieved.
Estimated Annual Respondent Burden
Exhibit 1 shows the estimated
annualized burden hours for the
respondents’ time to participate in this
evaluation. The total burden hours are
estimated to be 66, which covers two
years of interviews. The exhibits below
indicate annualized burden hours in
one year.
In-Depth Interviews with
Stakeholders: AHRQ plans to conduct
33 semi-structured interviews each year
for two years, totaling 66 semistructured interviews during the course
of the evaluation. These interviews will
be conducted with key HAI NAP
stakeholders with expertise in one or
more of the four targeted health care
settings. These health care settings
include: acute care hospital settings,
ambulatory surgical centers, ESRD
facilities, and long-term care settings.
Respondents will be interviewed by
telephone. Participant recruitment
should take no longer than five minutes.
Scheduling will take place through
email and will include an attached letter
of support from AHRQ. Interviews will
last up to one hour.
EXHIBIT 1—ESTIMATED ANNUALIZED BURDEN HOURS
Data collection activity
Number of
respondents
per year
Number of
responses per
respondent
Hours per
response
Total burden
hours
In-depth Interviews with HAI NAP Stakeholders with expertise pertaining to:
• Acute Care Hospital Settings ................................................................
• Ambulatory Surgical Centers ................................................................
• ESRD facilities ......................................................................................
• Long-Term Care Settings .....................................................................
9
8
8
8
........................
........................
1
1
1
1
........................
1
1
1
1
........................
9
8
8
8
Total ...................................................................................................
33
1
1
33
EXHIBIT 2—ESTIMATED ANNUALIZED COST BURDEN
Number of
respondents
Data collection activity
Total burden
hours
Average
hourly wage
rate
Total cost
burden
In-depth Interviews with external stakeholders:
• Acute Care Hospital Settings ................................................................
• Ambulatory Surgical Centers ................................................................
• ESRD facilities ......................................................................................
• Long-Term Care Settings .....................................................................
9
8
8
8
9
8
8
8
*$34.33
*34.33
*34.33
*34.33
$309.00
275.00
275.00
275.00
Total ...................................................................................................
33
na
na
1,134.00
rmajette on DSK2TPTVN1PROD with NOTICES
* Based upon May 2012 National Occupational Employment and Wage Estimates for Epidemiologists, retrieved from https://www.bls.gov/oes/
current/oesnat.htm#19–0000 on February 20, 2014.
Request for Comments
In accordance with the Paperwork
Reduction Act, comments on AHRQ’s
information collection are requested
with regard to any of the following: (a)
VerDate Mar<15>2010
15:02 Jul 28, 2014
Jkt 232001
Whether the proposed collection of
information is necessary for the proper
performance of AHRQ health care
research and health care information
dissemination functions, including
PO 00000
Frm 00035
Fmt 4703
Sfmt 4703
whether the information will have
practical utility; (b) the accuracy of
AHRQ’s estimate of burden (including
hours and costs) of the proposed
collection(s) of information; (c) ways to
E:\FR\FM\29JYN1.SGM
29JYN1
Federal Register / Vol. 79, No. 145 / Tuesday, July 29, 2014 / Notices
enhance the quality, utility, and clarity
of the information to be collected; and
(d) ways to minimize the burden of the
collection of information upon the
respondents, including the use of
automated collection techniques or
other forms of information technology.
Comments submitted in response to
this notice will be summarized and
included in the Agency’s subsequent
request for OMB approval of the
proposed information collection. All
comments will become a matter of
public record.
Dated: July 15, 2014.
Richard Kronick,
AHRQ Director.
BILLING CODE 4160–90–M
[FR Doc. 2014–17737 Filed 7–28–14; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Advisory Committee to the Director
(ACD), Centers for Disease Control and
Prevention—Health Disparities
Subcommittee (HDS)
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the following meeting of the
aforementioned subcommittee:
rmajette on DSK2TPTVN1PROD with NOTICES
Time and Date
10:00 a.m.–11:30 a.m. EDT, August
19, 2014.
PLACE: Teleconference.
STATUS: This meeting is open to the
public, limited only by the availability
of telephone ports. The public is
welcome to participate during the
public comment period, which is
tentatively scheduled from 11:20 to
11:30 a.m. To participate on the
teleconference, please dial (866) 763–
0273 and enter code 6158968.
PURPOSE: The Subcommittee will
provide advice to the CDC Director
through the ACD on strategic and other
health disparities and health equity
issues and provide guidance on
opportunities for CDC.
MATTERS FOR DISCUSSION: The Health
Disparities Subcommittee (HDS)
members will discuss progress to date
on the recommendations approved by
the CDC ACD in April 2014 and review
updates on previously established
priorities of the HDS.
The agenda is subject to change as
priorities dictate.
Jkt 232001
Center Parkway, Atlanta, Georgia 30345,
Telephone: (404) 498–6185.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Gary Johnson,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. 2014–17804 Filed 7–28–14; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
BILLING CODE 4163–18–P
Centers for Disease Control and
Prevention
15:02 Jul 28, 2014
Leandris Liburd, Ph.D., M.P.H., M.A.,
Designated Federal Officer, Health
Disparities Subcommittee, Advisory
Committee to the Director, CDC, 1600
Clifton Road NE., M/S K–77, Atlanta,
Georgia 30333. Telephone (770) 488–
8182, Email: LEL1@cdc.gov. The
Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2014–17660 Filed 7–28–14; 8:45 am]
VerDate Mar<15>2010
CONTACT PERSON FOR MORE INFORMATION:
44035
Centers for Disease Control and
Prevention
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Meetings; Board of Scientific
Counselors, Office of Infectious
Diseases (BSC, OID)
Centers for Disease Control and
Prevention
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC),
announces the following meeting of the
aforementioned committee:
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Initial Review
The meeting announced below
concerns the NIOSH Assessment of
Elastomeric Respirators in Healthcare
Environments, RFA–OH–14–009, initial
review.
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the aforementioned meeting:
Time and Date
1:00 p.m.–4:00 p.m., August 20, 2014
(Closed)
PLACE: Teleconference
STATUS: The meeting will be closed to
the public in accordance with
provisions set forth in Section 552b(c)
(4) and (6), Title 5 U.S.C., and the
Determination of the Director,
Management Analysis and Services
Office, CDC, pursuant to Public Law 92–
463.
MATTERS FOR DISCUSSION: The meeting
will include the initial review,
discussion, and evaluation of
applications received in response to the
‘‘NIOSH Assessment of Elastomeric
Respirators in Healthcare Environments,
RFA–OH–14–009.’’
CONTACT PERSON FOR MORE INFORMATION:
Donald Blackman, Ph.D., Scientific
Review Officer, CDC, 2400 Century
PO 00000
Frm 00036
Fmt 4703
Sfmt 4703
Time and Date
1:00–3:00 p.m. EDT, August 19, 2014
Place: Teleconference.
Status: The meeting is open to the
public; the toll free dial in number is 1–
877–951–7311 with a pass code of
7634914.
Purpose: The BSC, OID, provides
advice and guidance to the Secretary,
Department of Health and Human
Services; the Director, CDC; the
Director, OID; and the Directors of the
National Center for Immunization and
Respiratory Diseases, the National
Center for Emerging and Zoonotic
Infectious Diseases, and the National
Center for HIV/AIDS, Viral Hepatitis,
STD, and TB Prevention, CDC, in the
following areas: strategies, goals, and
priorities for programs; research within
the national centers; and overall
strategic direction and focus of OID and
the national centers.
Matters for Discussion: The following
topics will be discussed: (1) reports back
from the May 2014 BSC, OID, working
group meetings and (2) an update from
OID on recent outbreak responses and
national center priorities.
The agenda and any supplemental
material will be available at
www.cdc.gov/oid/BSC.html after August
10.
E:\FR\FM\29JYN1.SGM
29JYN1
]]>Agencies
[Federal Register Volume 79, Number 145 (Tuesday, July 29, 2014)]
[Notices]
[Pages 44033-44035]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-17660]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Agency for Healthcare Research and Quality
Agency Information Collection Activities: Proposed Collection;
Comment Request
AGENCY: Agency for Healthcare Research and Quality, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: This notice announces the intention of the Agency for
Healthcare Research and Quality (AHRQ) to request that the Office of
Management and Budget (OMB) approve the proposed information collection
project: ``Phase II of a Longitudinal Program Evaluation of Health and
Human Services (HHS) Healthcare Associated Infections (HAI) National
Action Plan (NAP).'' In accordance with the Paperwork Reduction Act, 44
U.S.C. 3501-3521, AHRQ invites the public to comment on this proposed
information collection.
This proposed information collection was previously published in
the Federal Register on April 23rd and allowed 60 days for public
comment. No comments were received. The purpose of this notice is to
allow an additional 30 days for public comment.
DATES: Comments on this notice must be received by August 28, 2014.
ADDRESSES: Written comments should be submitted to: Doris Lefkowitz,
Reports Clearance Officer, AHRQ, by email at
doris.lefkowitz@AHRQ.hhs.gov.
Copies of the proposed collection plans, data collection
instruments, and specific details on the estimated burden can be
obtained from the AHRQ Reports Clearance Officer.
FOR FURTHER INFORMATION CONTACT: Doris Lefkowitz, AHRQ Reports
Clearance Officer, (301) 427-1477, or by email at
doris.lefkowitz@AHRQ.hhs.gov.
SUPPLEMENTARY INFORMATION:
Proposed Project
Phase II of a Longitudinal Program Evaluation of Health and Human
Services (HHS) Healthcare Associated Infections (HAI) National Action
Plan (NAP)
This evaluation of HHS' Healthcare Associated Infections National
Action Plan will assess the efficacy, efficiency and coordination of
federal efforts to mitigate and prevent Healthcare Associated
Infections (HAIs). As such, the evaluation represents a critical
component of AHRQ's mission to promote health care quality improvement.
HAIs are infections that patients acquire while receiving treatment
for other conditions while in a health care setting. They affect care
in hospitals, -hereafter referred to as ``acute care-,'' ambulatory
care settings, and long-term care facilities, and represent a
significant cause of illness and death in the United States. Over one
million HAIs occur across health care settings every year.
In 2008, amidst growing demands on the health care system, rising
health care costs, and increasing concerns about antimicrobial-
resistant pathogens, HHS established a senior-level Steering Committee
for the Prevention of HAIs. Charged with improving coordination and
maximizing the efficiency of prevention efforts across HHS, the
Steering Committee released the first ``National Action Plan to Prevent
Health Care-Associated Infections'' (HAI NAP) in 2009. This plan
outlined a systematic and phased approach to reducing HAIs and
associated morbidity, mortality, and costs. Phase One of HAI NAP, which
concluded in 2012, focused on HAI prevention in acute care hospitals,
where data on prevention and the capacity to measure improvement were
most complete. Additionally, the plan set specific targets for reducing
rates of six high priority HAIs or specific causative organisms:
Surgical site infection (SSI), central-line associated bloodstream
infection (CLABSI), ventilator-associated pneumonia (VAP), catheter-
associated urinary tract infection (CAUTI), Clostridium difficile
infection, and methicillin-resistant Staphylococcus aureus infection
(MRSA).
Phase II of the Action Plan, entitled National Action Plan to
Prevent Healthcare-Associated Infections: Roadmap to Elimination was
released in April 2012. Phase 11 expanded the Action Plan to include
prevention of HAIs in ambulatory surgical centers (ASCs) and end-stage
renal disease (ESRD) facilities, and increasing influenza vaccination
coverage of health care personnel. Phase III of the HAI NAP, released
for public comment in April 2013, further expanded the Action Plan to
include prevention of HAIs in long-term care facilities.
Evaluation of HAI NAP. In 2009, AHRQ funded an independent, outside
evaluation of HHS' HAI prevention efforts, as guided by the Action
Plan. The goals of this evaluation were to: (1) Record the content and
scope of the Action Plan, its current design, its progress, and impact
on the future; (2) establish baseline data and provide additional
information on the HAT landscape prior to and following the initiation
of the Action Plan effort; and (3) provide strategic insights from
ongoing processes for reducing HAIs and outcomes of these processes.
The current evaluation will expand upon this initial effort,
encompassing the additional health care settings outlined in Phases H
and III of the HAI NAP.
The goals of this Phase II evaluation are to:
1. Identify commonalities, gaps, themes, and opportunities for
collaboration across six Federal quality improvement and patient safety
efforts to eliminate HAIs; and
2. highlight actionable opportunities across HHS to collaborate and
efficiently utilize resources in these quality improvement and patient
safety efforts; and
3. assess the unique and aggregate contributions of each quality
improvement and patient safety effort to the mitigation and prevention
of HAIs.
This study is being conducted by AHRQ through its contractor,
Insight Policy Research, Inc. and its subcontractors, IMPAQ
International and RAND Corporation, pursuant to AHRQ's statutory
authority to conduct and support research and evaluations on health
care and on systems for the delivery of such care, including activities
with respect to the quality, effectiveness, efficiency, appropriateness
and value of health care
[[Page 44034]]
services and with respect to quality measurement and improvement. 42
U.S.C. 299a(a)(1) and (2).
Method of Collection
To achieve the goals of the HAI NAP evaluation, the following data
collections will be implemented:
Semi-structured interviews. Key informant interviews with
stakeholders of the HAI National Action Plan or the Quality Improvement
(QI) initiatives that the Action Plan seeks to coordinate and align.
These stakeholders will have knowledge of the QI initiatives as
implemented in acute care, ambulatory care, long-term care or ESRD
facilities. AHRQ plans to conduct 33 interviews each year, over the
course of two years. The semi-structured interviews will inform the
process evaluation.
AHRQ will use the interview data to assess the processes and
methods used, results achieved, and lessons learned from patient
quality and safety programs that are directed at reducing the incidence
of HAIs. This information will enable AHRQ to identify redundancies in
program efforts and provide effective approaches for coordinating and
aligning Federal efforts to prevent the incidence of HAIs. Finally,
collecting data from these stakeholders will allow AHRQ to detect gaps
in the HAI science base and opportunities for funding additional
projects focused on generating and implementing knowledge on preventing
HAIs.
The information gathered through the key informant interviews will
be presented to members of a Federal Action Working Group (FAWG),
comprising representatives from the various Federal agencies and
operating divisions of MIS who are actively involved in the HAI NAP.
Presentations to the FAWG will provide continual and rapid-cycle
feedback on evaluation findings. This feedback will accomplish several
goals--namely, it will apprise the FAWG members of the study's
formative findings, provide a medium to obtain feedback from the FAWG
regarding the unique and aggregate impact of the national programs, and
engage the FAWG in a discussion about gaps and future requirements.
Ultimately, the information gathered through this data collection
effort will appear in annual reports, along with results of secondary
data analyses. These reports will provide AHRQ and HHS with
comprehensive, evaluative findings across and within individual patient
safety programs as well as findings specific to the HAI NAP, and the
extent to which the goals outlined in the plan have been achieved.
Estimated Annual Respondent Burden
Exhibit 1 shows the estimated annualized burden hours for the
respondents' time to participate in this evaluation. The total burden
hours are estimated to be 66, which covers two years of interviews. The
exhibits below indicate annualized burden hours in one year.
In-Depth Interviews with Stakeholders: AHRQ plans to conduct 33
semi-structured interviews each year for two years, totaling 66 semi-
structured interviews during the course of the evaluation. These
interviews will be conducted with key HAI NAP stakeholders with
expertise in one or more of the four targeted health care settings.
These health care settings include: acute care hospital settings,
ambulatory surgical centers, ESRD facilities, and long-term care
settings. Respondents will be interviewed by telephone. Participant
recruitment should take no longer than five minutes. Scheduling will
take place through email and will include an attached letter of support
from AHRQ. Interviews will last up to one hour.
Exhibit 1--Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Number of
Data collection activity respondents responses per Hours per Total burden
per year respondent response hours
----------------------------------------------------------------------------------------------------------------
In-depth Interviews with HAI NAP Stakeholders 9 .............. .............. ..............
with expertise pertaining to:
Acute Care Hospital Settings....... 8 1 1 9
Ambulatory Surgical Centers........ 8 1 1 8
ESRD facilities.................... 8 1 1 8
Long-Term Care Settings............ .............. 1 1 8
---------------------------------------------------------------
Total................................... 33 1 1 33
----------------------------------------------------------------------------------------------------------------
Exhibit 2--Estimated Annualized Cost Burden
----------------------------------------------------------------------------------------------------------------
Average
Data collection activity Number of Total burden hourly wage Total cost
respondents hours rate burden
----------------------------------------------------------------------------------------------------------------
In-depth Interviews with external stakeholders:
Acute Care Hospital Settings....... 9 9 *$34.33 $309.00
Ambulatory Surgical Centers........ 8 8 *34.33 275.00
ESRD facilities.................... 8 8 *34.33 275.00
Long-Term Care Settings............ 8 8 *34.33 275.00
---------------------------------------------------------------
Total................................... 33 na na 1,134.00
----------------------------------------------------------------------------------------------------------------
* Based upon May 2012 National Occupational Employment and Wage Estimates for Epidemiologists, retrieved from
https://www.bls.gov/oes/current/oesnat.htm#19-0000 on February 20, 2014.
Request for Comments
In accordance with the Paperwork Reduction Act, comments on AHRQ's
information collection are requested with regard to any of the
following: (a) Whether the proposed collection of information is
necessary for the proper performance of AHRQ health care research and
health care information dissemination functions, including whether the
information will have practical utility; (b) the accuracy of AHRQ's
estimate of burden (including hours and costs) of the proposed
collection(s) of information; (c) ways to
[[Page 44035]]
enhance the quality, utility, and clarity of the information to be
collected; and (d) ways to minimize the burden of the collection of
information upon the respondents, including the use of automated
collection techniques or other forms of information technology.
Comments submitted in response to this notice will be summarized
and included in the Agency's subsequent request for OMB approval of the
proposed information collection. All comments will become a matter of
public record.
Dated: July 15, 2014.
Richard Kronick,
AHRQ Director.
[FR Doc. 2014-17660 Filed 7-28-14; 8:45 am]
BILLING CODE 4160-90-M
